US Dental Soft-Tissue Regeneration Market (2024-2029)
The US Dental Soft-Tissue Regeneration Market was valued at $92.16 Million in 2024 and projected to reach to $141.39 Million by 2029, representing a compound annual growth rate of 8.9%. The US dental soft-tissue regeneration market is positioned for sustained expansion through 2029, driven by rising patient demand for minimally invasive periodontal treatments and implant-related procedures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Dental Soft-Tissue Regeneration Market Trends and Insights
- This expansion reflects increasing adoption of regenerative dental procedures across US clinical practices and growing patient demand for advanced periodontal and implant-related treatments.
- The US market benefits from strong healthcare infrastructure, high dental spending, and rising awareness of soft-tissue grafting and biomaterial solutions among US dental professionals. Driving this 8.9% compound annual growth rate, the US market is supported by technological innovations in scaffold materials, stem cell therapies, and growth factor applications tailored to US regulatory standards.
- US dental practitioners are increasingly integrating soft-tissue regeneration into routine implant and periodontal protocols, reflecting a shift toward preventive and restorative care.
- The forecast period through 2029 indicates sustained momentum as US insurers expand coverage and patient out-of-pocket costs become more manageable, further accelerating market penetration across US dental centers..
Key Market Statistics
- CAGR (2024-2029) 8.9% CAGR
- Market Size, 2024 ~USD 92.16 Million
- Forecast, 2029 ~USD 141.39 Million
- Country US
US Dental Soft-Tissue Regeneration Market Overview
Market Valuation :
The US dental soft-tissue regeneration market is valued at $92.16 million in 2024, with strong momentum driven by increasing adoption of regenerative procedures in American dental practices.
Robust Growth Trajectory :
The US market is projected to reach $141.39 million by 2029, representing an 8.9% CAGR—outpacing the global growth rate of 7.8%, indicating accelerating demand within the US healthcare system.
Clinical Practice Expansion :
Growing adoption of regenerative dental procedures across US clinical practices reflects increased patient awareness and dentist confidence in soft-tissue regeneration technologies for periodontal and implant applications.
Advanced Healthcare Infrastructure :
The US market benefits from strong healthcare infrastructure, high insurance coverage rates, and significant investment in dental innovation, supporting widespread implementation of regenerative solutions.
US Dental Soft-Tissue Regeneration Market Dynamics
- Increasing awareness of regenerative dentistry benefits, coupled with favorable reimbursement policies and strong clinical evidence, is accelerating adoption among US dental practitioners.
- The market will likely see continued innovation in biomaterial technologies and growth in specialized periodontal clinics offering advanced regenerative solutions. Key growth drivers include an aging US population requiring periodontal interventions, rising cosmetic dentistry trends, and integration of regenerative procedures into mainstream dental practice.
- Investment in dental education and training programs focused on soft-tissue regeneration will further support market expansion.
- The competitive landscape will intensify as major dental companies expand their regenerative product portfolios to capture growing US market share..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- The US market is valued at $92.16 million in 2024 and will reach $141.39 million by 2029, representing a strong 8.9% CAGR.
- US dental practitioners are rapidly adopting soft-tissue regeneration technologies, driven by improved clinical outcomes and patient demand for advanced periodontal solutions.
- Regulatory approval and insurance reimbursement expansion in the US are key catalysts accelerating market adoption through 2029.
- Technological innovations in biomaterials and growth factors are positioning the US as a leading market for soft-tissue regeneration solutions.
Dental Soft-Tissue Regeneration Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PERIODONTOLOGY (Application) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 7.8% from 2024 to 2029 |
| Largest Segment | AUTOGRAFTS (Product Type) |
| Market Size Base Year (Billions) | ~USD 0.34 (2024) |
| Revenue Forecast (Billions) | ~USD 0.54 (2029) |
| Segments Covered | Product Type, Application, End User |
US Dental Soft-Tissue Regeneration Market Report Segmentation
3 segment dimensions are covered across the global market.
By Product Type
- Autografts
- Collagen-Based Membranes
- Other Products
- Synthetic Biomaterials
By Application
- Implantology
- Other Applications
- Periodontology
By End User
- Academic & Research Institutes
- Dental Hospitals
- Dsos & Independent Clinics
US: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 12.3 | 12.5 | 12.9 | 13.4 | 14 | 14.8 | 15.8 | 17.1 | 5.8 |
| DENTAL HOSPITALS | 47.4 | 49 | 51.3 | 54.1 | 57.5 | 61.7 | 66.8 | 73.3 | 7.4 |
| DSOS & INDEPENDENT CLINICS | 79.6 | 83.5 | 88.7 | 94.8 | 102.2 | 111.2 | 122.2 | 135.9 | 8.9 |
| TOTAL | 139.3 | 145 | 152.9 | 162.4 | 173.8 | 187.7 | 204.9 | 226.4 | 8.2 |
Target Audience
- Dental Device Manufacturers : US-based and international dental companies need market-specific data to develop products aligned with American clinical standards, optimize US market entry strategies, and capture growing demand for regenerative solutions.
- Periodontal & Implant Specialists : US dental practitioners require market insights to understand emerging regenerative technologies, patient demand trends, and competitive offerings to enhance clinical capabilities and practice growth in soft-tissue regeneration.
- Healthcare Investors & PE Firms : Investment professionals targeting the US dental sector need comprehensive market data, growth forecasts, and competitive analysis to identify acquisition targets, funding opportunities, and portfolio optimization strategies.
- Dental Distributors & Suppliers : US dental supply companies require market intelligence on product demand, clinical adoption rates, and regional trends to optimize inventory, expand product lines, and strengthen relationships with dental practices.
- Healthcare Consultants & Analysts : Consulting firms and research organizations need US-specific market data to support client advisory services, competitive benchmarking, and strategic planning in the dental regeneration and periodontal treatment sectors.
Key Companies in the US Dental Soft-Tissue Regeneration Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HENRY SCHEIN, INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ENVISTA | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ZIMVIE INC. | United States | Private Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| DENTSPLY SIRONA INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ABBVIE INC. | United States | Public Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | United Kingdom | Public Company | Collagen-based Membranes,Synthetic Biomaterials,Autografts, |
| TISSUE REGENIX | United Kingdom | Private Company | Autografts,Synthetic Biomaterials,Collagen-based Membranes, |
| MECCELLIS BIOTECH | France | Collagen-based Membranes,Synthetic Biomaterials,Autografts, |
HENRY SCHEIN, INC.
Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.
ENVISTA
Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.
ZIMVIE INC.
Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.
DENTSPLY SIRONA INC.
Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.
ABBVIE INC.
AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.
ADVANCED MEDICAL SOLUTIONS GROUP PLC
Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.
TISSUE REGENIX
Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.
MECCELLIS BIOTECH
Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.
Reasons to Buy this Report
- Market Size & Growth Data : Access precise US market valuation ($92.16M in 2024) and 5-year forecast ($141.39M by 2029) with 8.9% CAGR to benchmark competitive positioning and identify growth opportunities specific to the American market.
- US-Specific Clinical Insights : Understand adoption patterns, clinical practice trends, and patient demand drivers unique to the US healthcare system, enabling targeted product development and market entry strategies for regenerative dental solutions.
- Competitive Landscape Analysis : Gain intelligence on US market competitors, product portfolios, and differentiation strategies to inform competitive positioning and identify white-space opportunities in the American soft-tissue regeneration segment.
- Reimbursement & Regulatory Context : Leverage US-focused analysis of insurance coverage, reimbursement policies, and regulatory pathways to optimize commercialization strategies and accelerate market penetration in American dental practices.
- Strategic Investment Decisions : Make informed investment and partnership decisions based on comprehensive US market data, growth projections, and emerging trends to maximize ROI in the high-potential American dental regeneration market.
Frequently asked questions
What is the current size of the US dental soft-tissue regeneration market?
The US dental soft-tissue regeneration market was valued at $92.16 million in 2024 and is expected to grow to $141.39 million by 2029.
What is the projected growth rate for the US market through 2029?
The US market is projected to grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2029.
What are the primary drivers of growth in the US dental soft-tissue regeneration market?
Key drivers include increasing adoption of regenerative procedures by US dental practitioners, technological innovations in biomaterials and growth factors, expanding insurance reimbursement, and rising patient awareness of advanced periodontal treatments.
Which applications are most prevalent in the US soft-tissue regeneration market?
The US market is dominated by applications in periodontal regeneration, implant site development, and graft procedures, with growing adoption in aesthetic dentistry and ridge augmentation.
How does the US market compare to global trends in dental soft-tissue regeneration?
The US market grows at 8.9% CAGR, outpacing the global average of 7.8%, reflecting stronger healthcare infrastructure, higher dental spending, and faster adoption of advanced regenerative technologies in the US.
RESEARCH METHODOLOGY
This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.
Secondary Research
The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.
Primary Research
In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.
A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
- Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global diagnostics market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom-up Approach & Top-down Approach)
Data Triangulation
After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.
Market Definition
Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.
Stakeholders
- Dental soft-tissue regenerative material manufacturing companies
- Distributors and suppliers of dental soft-tissue regeneration products
- Medical device companies
- Research and consulting firms
- Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
- Research institutes and academic centers
- Contract research organizations (CROs)
- Government associations
- Venture capitalists and investors
Report Objectives
- To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
- To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
- To analyze the generative AI impact on the dental soft-tissue regeneration market
Get the Full Dental Soft-Tissue Regeneration Market Report
Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.
- Canada Dental Soft-Tissue Regeneration Market
- Germany Dental Soft-Tissue Regeneration Market
- UK Dental Soft-Tissue Regeneration Market
- France Dental Soft-Tissue Regeneration Market
- Spain Dental Soft-Tissue Regeneration Market
- Italy Dental Soft-Tissue Regeneration Market
- Japan Dental Soft-Tissue Regeneration Market
- China Dental Soft-Tissue Regeneration Market
- India Dental Soft-Tissue Regeneration Market
- Australia Dental Soft-Tissue Regeneration Market
- South Korea Dental Soft-Tissue Regeneration Market
- Brazil Dental Soft-Tissue Regeneration Market
- Mexico Dental Soft-Tissue Regeneration Market
- Argentina Dental Soft-Tissue Regeneration Market
- GCC Countries Dental Soft-Tissue Regeneration Market
- Rest Of Asia Pacific Dental Soft-Tissue Regeneration Market
- Rest Of Europe Dental Soft-Tissue Regeneration Market
- Rest Of Latin America Dental Soft-Tissue Regeneration Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
